Eurizon Capital SGR S.p.A. Sells 19,573 Shares of Pediatrix Medical Group, Inc. $MD

Eurizon Capital SGR S.p.A. reduced its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 42.9% during the 3rd quarter, Holdings Channel.com reports. The fund owned 26,046 shares of the company’s stock after selling 19,573 shares during the quarter. Eurizon Capital SGR S.p.A.’s holdings in Pediatrix Medical Group were worth $670,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. BlackRock Inc. acquired a new stake in Pediatrix Medical Group during the 2nd quarter worth approximately $347,383,000. Bank of New York Mellon Corp acquired a new stake in Pediatrix Medical Group in the second quarter valued at about $14,297,000. Empowered Funds LLC acquired a new stake in shares of Pediatrix Medical Group in the second quarter valued at about $12,668,000. Allspring Global Investments Holdings LLC boosted its stake in shares of Pediatrix Medical Group by 27.9% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,070,961 shares of the company’s stock worth $53,348,000 after acquiring an additional 452,051 shares in the last quarter. Finally, Wasatch Advisors LP boosted its position in Pediatrix Medical Group by 21.9% during the second quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company’s stock worth $63,297,000 after purchasing an additional 448,360 shares in the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Trading Down 2.2%

Shares of NYSE MD opened at $31.18 on Wednesday. The business has a fifty day simple moving average of $28.06 and a 200-day simple moving average of $24.45. The company has a market cap of $2.44 billion, a price-to-earnings ratio of 16.95 and a beta of 0.62. Pediatrix Medical Group, Inc. has a 12 month low of $17.23 and a 12 month high of $33.74. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 0.47.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.07. The company had revenue of $501.37 million during the quarter, compared to analyst estimates of $498.18 million. Pediatrix Medical Group had a net margin of 7.66% and a return on equity of 20.12%. The business’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.67 earnings per share. Sell-side analysts predict that Pediatrix Medical Group, Inc. will post 2.22 EPS for the current year.

Analyst Ratings Changes

MD has been the subject of several recent research reports. Mizuho downgraded Pediatrix Medical Group from a “neutral” rating to an “underperform” rating and set a $28.00 price target for the company. in a research report on Wednesday, November 11th. Weiss Ratings raised shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, September 9th. Deutsche Bank reaffirmed a “hold” rating and set a $25.00 price target on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th. Truist Financial increased their price target on Pediatrix Medical Group from $28.00 to $31.00 and gave the stock a “hold” rating in a research report on Friday, October 30th. Finally, Jefferies Financial Group downgraded Pediatrix Medical Group from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $27.00 to $28.00 in a research report on Wednesday, August 19th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $28.00.

View Our Latest Stock Analysis on MD

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.

Further Reading

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.